EDITORIAL
Accepted on 02 Oct 2025
Exploring the expanding therapeutic value of glucose-dependent insulinotropic polypeptide receptor signaling. An editorial for "The Impact of GIP/GIPR on Metabolic Diseases: How the Field Is Evolving"
doi 10.3389/fendo.2025.1710843
- 412 views